SCHEMBL22092795

SCHEMBL22092795

CC(C)(OC(=O)C(F)(F)F)[C@H]1CCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22089735 1.00 — —
SCHEMBL22092812 1.00 — —
SCHEMBL28296656 0.85 — —
SCHEMBL28631775 0.74 SLC1A2 (0.31) —
Trifluoroacetic Acid SCHEMBL22092794 0.69 ALDH1A1 (0.33) —
Trifluoroacetic Acid SCHEMBL22089734 0.69 ALDH1A1 (0.33) —
Trifluoroacetic Acid SCHEMBL22092810 0.69 ALDH1A1 (0.33) —
SCHEMBL5142865 0.68 SLC6A3 (0.31) —
Trifluoroacetic Acid SCHEMBL26606130 0.66 SLC1A2 (0.35) —
SCHEMBL23415593 0.66 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210363152-A1 AMINOAZINE AMIDES HOFFMANN LA ROCHE (US) 2021-11-25 — — US disclosed
EP-3873473-A1 AMINOAZINE AMIDES F. Hoffmann-La Roche AG (CH) 2021-09-08 — — EP disclosed
WO-2020123426-A1 AMINOAZINE AMIDES F. HOFFMANN-LA ROCHE AG (CH) 2020-06-18 — — WO disclosed
US-20160250246-A1 ORAL FORMULATIONS OF CYTIDINE ANALOGS AND METHODS OF USE THEREOF CELGENE CORP (US) 2016-09-01 — — US disclosed
Send feedback